التفاصيل البيبلوغرافية
| العنوان: |
Intrapleural fibrinolytic therapy for pleural infections: Outcomes from a cohort study. |
| المؤلفون: |
Khai Wern Yong, Glenn, Jia Jun Wong, Jonathan, Xiaoe Zhang, Pei Sze Tan, Carmen, Xiao Na Wang, Poh Seo Quek, Kim Hoong Yap |
| المصدر: |
Annals of the Academy of Medicine, Singapore; Dec2024, Vol. 53 Issue 12, p724-733, 10p |
| مصطلحات موضوعية: |
THROMBOLYTIC therapy, CHEST tubes, ASIANS, PULMONOLOGY, COMMUNICABLE diseases |
| مستخلص: |
Introduction: Pleural infections are a significant cause of mortality. Intrapleural fibrinolytic therapy (IPFT) utilising alteplase and dornase is a treatment option for patients unsuitable for surgery. The optimal dose of alteplase is unknown, and factors affecting treatment success in an Asian population are unclear. We sought to determine the factors affecting treatment success in Tan Tock Seng Hospital, Singapore and evaluate the efficacy of lower doses of IPFT. Method: A retrospective analysis of patients with pleural infections treated with IPFT between July 2016 and November 2023 was performed. Treatment success was defined as survival without surgery at 3 months. Data, including patient demographics; comorbidities; RAPID (renal, age, purulence, infection source and dietary factor) scores; and radiological characteristics, were extracted from medical records and analysed. Linear mixed effects model and logistic regression were performed to determine factors affecting treatment success. Results: A total of 131 cases were analysed. Of these, 51 (38.9%) reported positive pleural fluid culture, and the most common organism was Streptoccocus anginosus. Mean age was 65 years (standard deviation [SD] 15.5). Mean time from chest tube insertion to first dose of IPFT was 10.2 days (SD 11.5). Median starting dose of alteplase was 5 mg. Treatment success was reported in 112 cases (85.5%). There were no significant differences between the alteplase dose and radiological clearance. Patient age (odds ratio [OR] 0.94, confidence interval [CI] 0.89-0.98) and interval between chest tube insertion to first dose (OR 0.95, CI 0.91-0.99) were statistically significant variables for the treatment success. Conclusion: Lower starting doses of alteplase remain effective in the treatment of pleural infection. Early IPFT may result in better outcomes. [ABSTRACT FROM AUTHOR] |
|
Copyright of Annals of the Academy of Medicine, Singapore is the property of Academy of Medicine Singapore and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |